Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference41 articles.
1. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. Apr 25 2014;114:1453–68.
2. Providencia R, Defaye P, Lambiase PD, Pavin D, Cebron JP, Halimi F, et al. Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible? Europace Jan. 2017;19:48–57.
3. Andrade JG, Khairy P, Dubuc M. Catheter cryoablation: biology and clinical uses. Circ Arrhythm Electrophysiol. 2013;6:218–27.
4. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374:2235–45.
5. Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circulation. 2019;140:1779–88 Randomised clinical trial evaluating advanced generation catheter ablation technologies (contact-force guided RF ablation and second-generation cryoballoon-based ablation), and cryoballoon freeze duration. The study demonstrated substantial reductions in atrial fibrillation burden, with comparable safety and efficacy outcomes across the evaluated technologies and cryoablation durations.